Company Filing History:
Years Active: 2013
Title: Suiwei An: Innovator in Pharmaceutical Chemistry
Introduction
Suiwei An is a notable inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of anti-infection compounds. His work is characterized by a focus on innovative methods for synthesizing optically active compounds.
Latest Patents
Suiwei An holds a patent for an optically active compound of prulifloxacin, which is used for treating infections. The patent details an anti-infection levorotatory optically active compound (S-configuration) of prulifloxacin, represented by a specific chemical formula. The preparation method involves using levorotatory ulifloxacin as the raw material, with the reaction conducted in an organic solvent in the presence of alkaline materials. The reaction temperature ranges from -20°C to 60°C, and the reaction time varies from 15 minutes to 24 hours. This innovative approach enhances the efficacy of prulifloxacin in treating infections.
Career Highlights
Suiwei An is currently employed at Hainan Hualon Pharmaceutical Co., Ltd., where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in developing new therapeutic agents that address pressing health concerns.
Collaborations
Suiwei An collaborates with several professionals in his field, including Jun Ying and Feng Peng. These collaborations foster a dynamic research environment that encourages the exchange of ideas and expertise.
Conclusion
Suiwei An's contributions to pharmaceutical chemistry, particularly through his patent on prulifloxacin, highlight his role as an innovator in the field. His work not only advances scientific knowledge but also has the potential to improve treatment options for infections.